top of page
Finally, Therapeutics that slow Alzheimer’s...
But, which is the best?
Jul 16, 2023
New Era In Alzheimer's Treatments Brings Opportunities for Biopharma Investors
ALHEIMER’S BREAKTHROUGH
Jun 19, 2023
Mar 30, 2023
Over 20 Smid-Cap Biopharmas Presenting at AACR 2023!
Originally posted: 3/16/23; last updated 4/12/23
Mar 16, 2023
Mar 1, 2023
Feb 1, 2023
How does Lecanemab compare to other Alzheimer's assets?
Summary: Biogen and Eisai's asset Lecanemab has a PDUFA date set for Friday 1/6/23 Lecanemab targets and effectively reduces beta-amyloid...
Jan 4, 2023
Jan 4, 2023
Updated Smid-cap Biopharma Companies Acquired 2022
(Originally posted 7/25/2022, updated 7/27/22) Summary BPIQ monitors mergers and acquisitions (M&A's) of smid-cap biopharmas Acquisition...
Jul 25, 2022
Jump start your biotech due diligence
Our platform helps you uncover your next biotech investment opportunity
bottom of page